查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928331

全球伽瑪放射源市場（按來源類型、產品形式、放射性水平、應用、最終用戶和銷售管道分類）預測（2026-2032年）

Gamma Radioactive Sources Market by Source Type, Product Form, Activity Level, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，伽馬射線放射源市場價值將達到 27.8 億美元，到 2026 年將成長至 29.7 億美元，到 2032 年將達到 43.1 億美元，複合年成長率為 6.44%。

關鍵市場統計數據
基準年 2025 27.8億美元
預計年份：2026年 29.7億美元
預測年份 2032 43.1億美元
複合年成長率 (%) 6.44%

本書權威地概述了影響當代伽馬射線放射源應用決策的運作、監管和技術因素。

伽馬射線放射源處於先進技術、法律規範以及專業工業和醫療應用的關鍵交匯點。以下概述闡述了影響當前相關人員優先事項的關鍵背景：供應鏈韌性、合規性、放射治療和滅菌技術的進步，以及對安全和環境保護日益成長的重視。對於必須在業務連續性和不斷變化的風險管理要求之間取得平衡的高階主管、技術領導者和政策顧問而言，理解這些背景至關重要。

技術、監管和價值鏈的變革正在融合，重新定義各行業的供應商價值提案和最終用戶期望。

伽瑪射線放射源領域正經歷變革性的轉變，這主要受技術創新、政策調整以及終端用戶需求變化的驅動。包裝技術和活度濃度評級的進步提高了放射源的壽命和安全性，使其能夠在要求嚴苛的醫療和工業環境中廣泛應用。同時，影像導航放射治療和近距離放射治療系統的進步正在改變臨床工作流程，並影響放射源的需求類型，促使人們傾向於選擇能夠實現精確劑量管理和簡化操作流程的解決方案。

對美國關稅調整對產業採購經濟、供應鏈結構和服務交付模式的影響進行實證檢驗

美國關稅政策自2025年前後開始實施，其累積影響導致與伽馬射線放射源相關的供應鏈、籌資策略和成本結構發生重大調整。關稅波動推高了部分進口零件和成品的成本，迫使相關相關人員重新評估採購區域和供應商合約。為此，許多企業加快了供應鏈多元化、增加本地庫存以及尋找替代零件供應商的步伐，以維持服務連續性並管控採購風險。

多層細分分析揭示了應用、放射源化學成分、最終用戶、產品形式、銷售管道和活動水平如何決定策略重點和營運風險。

關鍵細分分析揭示了應用、放射性物質類型、最終用戶、產品形式、銷售管道和活動水平等方面的顯著差異，這些差異塑造了相應的策略和營運重點。依應用領域分類，伽馬源可用於環境監測、食品輻照、工業輻射檢驗、醫療放射治療、石油天然氣、研發和滅菌。醫療放射治療又可細分為近距離放射和體外放射治療，其中近距離放射已通過高劑量率和低劑量率應用案例得到驗證。這種分層應用分類揭示了臨床應用模式的差異。具體而言，對具有特定活度分佈的近距離近距離放射源的需求集中在那些將微創照射和局部劑量控制作為臨床優先事項的領域。同時，滅菌和食品輻照則強調可靠的物流和監管可追溯性。

區域比較評估顯示了美洲、歐洲、中東和非洲以及亞太市場在法規、能力和需求特徵方面的差異，這些差異會影響戰略合作。

區域趨勢將對美洲、歐洲、中東和非洲以及亞太地區的供應鏈、法規結構和需求模式產生重大影響。美洲擁有完善的技術服務生態系統和成熟的臨床市場，因此對醫用放射源和滅菌服務的需求持續成長。北美地區的法律規範強調嚴格的許可和追蹤，這雖然增加了合規負擔，但也為提供生命週期管理和安全物流解決方案的供應商創造了機會。拉丁美洲市場對醫療和工業應用的興趣日益濃厚，這主要得益於對醫療基礎設施和食品加工能力的大量投資。

企業環境分析重點闡述了綜合服務產品、監管專業知識和地理企業發展如何決定服務提供者之間的競爭優勢。

主要企業的洞察凸顯了透過整合服務模式、監管能力和供應鏈韌性來實現策略差異化的重要性。市場領導和創新新參與企業都在投資於超越核心放射源製造的能力，涵蓋校準、運輸物流、安全儲存和廢棄物處理等全生命週期服務。提供端到端解決方案的公司更有利於贏得那些尋求外包複雜合規活動並降低營運風險的客戶。製造商、物流專家和監管諮詢公司之間的策略聯盟日益普遍，從而能夠提供應對技術、法律和營運挑戰的綜合服務。

為高階主管提供切實可行的行動計劃，以加強其價值鏈、拓展附加價值服務，並使產品系列與監管和營運實際情況保持一致。

產業領導者應優先採取切實可行的措施，以增強韌性、確保合規並抓住策略機會。首先，實施模組化供應鏈策略，將關鍵供應商與經過審核的區域合作夥伴結合，以減少對單一供應商的依賴並縮短前置作業時間。其次，投資強大的生命週期管理服務，包括安全運輸、維護和處置，從而將複雜的監管環境轉化為差異化的服務提案。第三，透過加強監管情報能力，預測政策變化並相應地調整合約條款、定價結構和庫存管理政策，從而最大限度地降低與關稅和合規變化相關的財務風險。

我們採用透明且多方位的研究途徑，結合專家訪談、文件審查和跨司法管轄區分析，以確保得出可靠且可操作的研究結果。

本分析的調查方法結合了定性專家訪談、與供應商和最終用戶的結構化對話以及嚴謹的文件審查，以確保獲得平衡且檢驗的見解。我們首先對臨床、工業和研究領域的資深技術領導、採購負責人和監管專家進行了訪談，以了解他們對供應可靠性、服務期望和合規挑戰的第一手觀點。此外，我們也與物流供應商和安全專家進行了有針對性的討論，以了解不同業務量和產品形式所帶來的運輸和倉儲限制。

一份簡明扼要的摘要，重點闡述了監管前瞻性、服務整合和供應鏈韌性將如何決定產業的長期策略成果。

總之，伽瑪射線放射源的市場環境具有技術專業化需求、不斷演變的管理體制以及對穩健的供應和服務模式的策略性需求等特徵。能夠根據特定應用的細微需求調整產品供應並投資於全生命週期服務的企業，將更有能力將監管的複雜性轉化為競爭優勢。關稅驅動的採購調整、區域能力差異以及包裝和運輸技術的進步相互作用，既帶來了風險，也為企業提供了差異化發展的機會。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按源類型分類的伽瑪放射源市場

  • 鋂-241
  • 銫-137
  • 鈷60
  • 銥-192

9. 依產品類型分類的伽瑪放射源市場

  • 密封型
  • 未密封

10. 按活度分類的伽瑪放射源市場

  • 高放射性
  • 低放射性
  • 中等放射性

第11章 依應用分類的伽瑪放射源市場

  • 環境監測
  • 食品輻照
  • 工業射線照相
  • 醫用放射治療
    • 近距離放射治療
      • 高劑量率
      • 低劑量率
    • 體外放射治療
  • 石油和天然氣
  • 研究與開發
  • 無菌

12. 依最終用戶分類的伽瑪放射源市場

  • 食品加工公司
  • 醫院
  • 核能發電廠
  • 石油和天然氣公司
  • 製藥公司
  • 研究所

第13章 伽瑪放射源市場（依銷售管道）

  • 直銷
  • 經銷商
  • 線上平台

14. 各地區伽瑪放射源市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 伽瑪放射源市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國伽瑪放射源市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國伽瑪放射源市場

第18章 中國伽瑪放射源市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Beijing Atom Hi-Tech Co., Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Board of Radiation and Isotope Technology
  • China Isotope & Radiation Corporation
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • Institut national des radioelements SA
  • International Isotopes Inc.
  • Isotope Technologies Dresden GmbH
  • NTP Radioisotopes SOC Ltd
  • Nuclear Technology Products（Pty）Ltd
  • Rosatom State Atomic Energy Corporation
  • Sotera Health LLC
Product Code: MRR-92740D85EF48

The Gamma Radioactive Sources Market was valued at USD 2.78 billion in 2025 and is projected to grow to USD 2.97 billion in 2026, with a CAGR of 6.44%, reaching USD 4.31 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.78 billion
Estimated Year [2026] USD 2.97 billion
Forecast Year [2032] USD 4.31 billion
CAGR (%) 6.44%

An authoritative overview of the operational, regulatory, and technological forces shaping contemporary decision-making across gamma radioactive source applications

Gamma radioactive sources inhabit a critical intersection of advanced technologies, regulatory oversight, and specialized industrial and medical applications. The introduction that follows outlines the essential context shaping contemporary stakeholder priorities: supply chain resilience, regulatory compliance, technological evolution in radiotherapy and sterilization, and the heightened emphasis on safety and environmental stewardship. Understanding this context is foundational for executives, technical leads, and policy advisers who must balance operational continuity with evolving risk management requirements.

Over recent years, the industry has experienced shifts in procurement patterns, lifecycle management of sealed and unsealed sources, and end-user expectations around service provision and regulatory support. These dynamics are driven by converging forces, including innovation in source encapsulation and activity grading, renewed investments in medical radiotherapy infrastructure, and demand for reliable sterilization processes in pharmaceutical and food sectors. Consequently, organizations are re-evaluating vendor relationships, logistics strategies, and internal capabilities to maintain continuity in mission-critical applications.

This introduction sets the stage for a deeper exploration of transformative market shifts, policy impacts, segmentation-specific insights, and regional dynamics. As readers progress through the analysis, the intent is to equip them with contextually rich perspectives that inform procurement, risk mitigation, and strategic investments without presuming a single path forward, recognizing that local regulation and application-specific requirements will shape optimal decisions.

A synthesis of technological, regulatory, and supply chain transformations redefining supplier value propositions and end-user expectations across the industry

The landscape for gamma radioactive sources is undergoing transformative shifts driven by technological innovation, policy recalibration, and changing end-user expectations. Technological advances in encapsulation techniques and activity grading have improved source longevity and safety profiles, enabling expanded adoption in demanding medical and industrial environments. At the same time, advances in imaging-guided radiotherapy and brachytherapy delivery systems are altering clinical workflows and influencing the types of sources in demand, favoring solutions that enable precision dosing and streamlined handling protocols.

Policy and regulatory pressures are simultaneously intensifying, with governments and international agencies enhancing requirements for tracking, transport, and disposal of radioactive materials. These regulatory shifts create both compliance costs and opportunities for service providers who can demonstrably reduce lifecycle risks for customers. In parallel, supply chain resilience has become a strategic focal point; manufacturers and end users are exploring dual-sourcing, localized inventories, and stronger contractual protections to mitigate disruptions caused by raw material constraints, geopolitical tensions, and logistic bottlenecks.

Finally, the end-user landscape is evolving. Hospitals and research institutions increasingly demand turnkey solutions that combine source supply with technical service and regulatory support, while food processors and pharmaceutical manufacturers prioritize reliability and traceability. This confluence of factors is reshaping supplier value propositions and accelerating collaboration between technology providers, logistics specialists, and regulatory consultants to deliver safe, compliant, and dependable solutions.

An evidence-based examination of how U.S. tariff adjustments have reshaped sourcing economics, supply chain architectures, and service delivery models in the sector

The cumulative impact of U.S. tariff policies introduced in and around 2025 has introduced material adjustments across supply chains, procurement strategies, and cost structures associated with gamma radioactive sources. Tariff-related shifts increased the cost of certain imported components and finished products, prompting stakeholders to re-evaluate sourcing geographies and supplier contracts. In response, many organizations have accelerated efforts to diversify supply bases, increase local inventory holdings, and seek alternative component suppliers to preserve service continuity and control procurement risk.

Tariffs have also influenced the broader economics of cross-border service provision. For international service providers that rely on the movement of sealed sources, adjustments in customs duties and associated administrative requirements have increased the complexity of international deployments. This has motivated a rise in regional partnerships and localized service hubs to reduce cross-border movements of high-activity sources and to meet client timelines more predictably. Consequently, service models emphasizing local technical support, maintenance, and regulatory liaison have become more attractive.

Moreover, tariffs have indirectly shaped investment decisions. Procurement teams are reassessing total cost of ownership metrics to account for tariff variability and logistics complexity, while suppliers are exploring nearshoring or regional manufacturing investments to shield customers from future trade-policy shocks. Stakeholders who proactively adapted contractual terms, hedged supply commitments, and engaged in scenario planning have been better positioned to maintain operational continuity and protect margins in a more volatile trade environment.

A layered segmentation analysis revealing how applications, source chemistries, end users, product forms, sales channels, and activity levels determine strategic priorities and operational risks

Key segmentation insights reveal differentiated dynamics across applications, source types, end users, product forms, sales channels, and activity levels that shape strategy and operational focus. Based on application, gamma sources serve Environmental Monitoring, Food Irradiation, Industrial Radiography, Medical Radiotherapy, Oil and Gas, Research and Development, and Sterilization, with Medical Radiotherapy further subdivided into Brachytherapy and External Beam Radiotherapy, and Brachytherapy examined through High Dose Rate and Low Dose Rate use cases. This layered application taxonomy clarifies that clinical adoption patterns are uneven: demand for brachytherapy sources with specific activity profiles is concentrated where minimally invasive delivery and localized dose control are clinical priorities, while sterilization and food irradiation emphasize high-reliability logistics and regulatory traceability.

Based on source type, common materials such as Americium 241, Cesium 137, Cobalt 60, and Iridium 192 display distinct handling, lifecycle, and disposal profiles that influence procurement and service decisions. For example, Cobalt 60's prevalence in sterilization reflects its activity characteristics and penetration properties, while Iridium 192's role in industrial radiography is linked to its suitability for portable inspection systems. Based on end user, the market serves Food Processing Companies, Hospitals, Nuclear Power Plants, Oil and Gas Companies, Pharmaceuticals, and Research Institutions, each with unique procurement cycles, regulatory oversight, and value drivers. Food processors and pharmaceutical manufacturers prioritize sterilization throughput and documentation, hospitals emphasize clinical outcomes and safety protocols, and nuclear facilities focus on reliability and lifecycle planning.

Based on product form, the distinction between Sealed and Unsealed sources is fundamental: sealed sources reduce contamination risk and simplify handling while unsealed sources enable particular diagnostic and therapeutic modalities but demand stringent containment and waste management practices. Based on sales channel, Direct Sales, Distributors, and Online Platforms each deliver different levels of technical support, supply assurance, and contractual protections, with direct sales often preferred for high-activity or customized solutions due to the need for integrated service and regulatory support. Finally, based on activity level, High Activity, Medium Activity, and Low Activity classifications determine transport regimes, storage complexity, and the intensity of regulatory oversight, with high-activity sources requiring the most rigorous controls and specialized logistics.

A comparative regional assessment showing how Americas, Europe Middle East & Africa, and Asia-Pacific markets differ in regulation, capability, and demand profiles influencing strategic engagement

Regional dynamics materially influence supply chains, regulatory frameworks, and demand patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, strengths include established technical service ecosystems and mature clinical markets that drive continuous demand for medical radiotherapy sources and sterilization services. North American regulatory structures emphasize rigorous licensing and tracking, which increases compliance burden but also creates opportunities for providers offering lifecycle management and secure logistics solutions. Latin American markets show growing interest in medical and industrial applications, often catalyzed by targeted investments in healthcare infrastructure and food processing capabilities.

Europe, Middle East & Africa presents a heterogeneous environment where robust regulatory harmonization across many European nations contrasts with variable regulatory and infrastructure capacities in parts of the Middle East and Africa. This diversity necessitates flexible market entry and localized partnerships, particularly where import controls and radiological safety programs differ. European demand trends center on precision radiotherapy and stringent environmental monitoring, while some Middle Eastern markets demonstrate rapid growth in healthcare infrastructure and industrial applications. Across Africa, demand is concentrated in niche research and specialized industrial applications, creating opportunities for capacity-building collaborations.

Asia-Pacific is characterized by a mix of high-volume manufacturing hubs, large clinical markets, and rapidly modernizing regulatory regimes. Several markets in the region are investing heavily in cancer care infrastructure and sterilization capacity, which drives demand for reliable sources and integrated services. At the same time, Asia-Pacific supply chains for source components and encapsulation materials play a pivotal role globally, underscoring the strategic importance of regional dynamics for manufacturers and service providers worldwide.

A corporate landscape analysis highlighting how integrated service offerings, regulatory expertise, and regional operations define competitive advantage among providers

Key company insights emphasize strategic differentiation through integrated service models, regulatory competence, and supply chain resilience. Market leaders and innovative entrants alike are investing in capabilities that extend beyond core source manufacturing to include lifecycle services such as calibration, transport logistics, secure storage, and end-of-life disposal. Companies that offer end-to-end solutions are better positioned to capture customers seeking to outsource complex compliance tasks and to reduce operational risk. Strategic partnerships between manufacturers, logistics specialists, and regulatory consultancies are increasingly common, enabling bundled offerings that address client pain points across technical, legal, and operational domains.

In addition, successful companies are leveraging product portfolio diversification to match distinct application requirements, for instance by supplying both high-activity sealed sources for sterilization and low-activity materials suitable for certain medical applications. Investment in quality management systems and international certification helps differentiate suppliers in markets with tight regulatory oversight. Firms that maintain regional service hubs and trained local technicians reduce deployment lead times and provide customers with more reliable support. Finally, competitive dynamics are influenced by the capacity for innovation in encapsulation and source lifecycle management, with those advancing safer handling solutions and containerization standards gaining credibility with risk-conscious buyers.

A practical action plan for senior executives to fortify supply chains, expand value-added services, and align product portfolios with regulatory and operational realities

Industry leaders should prioritize a set of actionable measures to strengthen resilience, ensure compliance, and capture strategic opportunities. First, implement modular supply strategies that combine primary suppliers with vetted regional partners to reduce single-point dependencies and shorten lead times. Second, invest in robust lifecycle management services that encompass secure transport, maintenance, and end-of-life disposal, thereby converting regulatory complexity into a differentiating service proposition. Third, enhance regulatory intelligence capabilities to anticipate policy shifts and adapt contract terms, pricing structures, and inventory policies accordingly, minimizing financial exposure to tariff and compliance changes.

Leaders should also pursue targeted investments in technical training and regional service hubs to improve responsiveness and reduce operational downtime. These investments will pay dividends in customer retention and in the ability to bid for complex, compliance-sensitive contracts. Additionally, develop product portfolios that address the specific needs of key end-user segments-offering tailored solutions for sterilization throughput, brachytherapy source profiles, industrial radiography portability, and research-grade formulations-while maintaining high standards for safety and traceability. Finally, engage proactively with regulators and industry consortia to shape pragmatic standards that balance safety with operational feasibility, thereby reducing uncertainty and fostering sustainable market growth.

A transparent and triangulated research approach blending expert interviews, documentary review, and cross-jurisdictional analysis to ensure credible and actionable findings

The research methodology underpinning this analysis combines qualitative expert interviews, structured supplier and end-user engagement, and rigorous documentary review to ensure balanced and verifiable insights. Primary interviews were conducted with senior technical leaders, procurement professionals, and regulatory specialists across clinical, industrial, and research settings to capture on-the-ground perspectives about supply reliability, service expectations, and compliance challenges. These interviews were supplemented by targeted consultations with logistics providers and safety specialists to understand transport and storage constraints associated with varying activity levels and product forms.

Secondary research encompassed comprehensive review of publicly available regulatory guidelines, industry standards, and technical literature relevant to source handling, encapsulation methods, and waste management practices. Where possible, cross-jurisdictional comparisons were used to highlight differences in licensing, transport, and disposal requirements. The methodology emphasizes triangulation of evidence-validating primary interview findings against documented regulations and technical white papers-to produce a coherent and defensible set of insights. Throughout, care was taken to avoid proprietary data disclosure and to respect confidentiality agreements with contributors, while ensuring that conclusions are grounded in observable practices and recognized regulatory frameworks.

A concise synthesis highlighting how regulatory foresight, service integration, and supply chain resilience determine long-term strategic outcomes in the industry

In conclusion, the gamma radioactive sources landscape is defined by technically specific demand, evolving regulatory regimes, and the strategic imperative for resilient supply and service models. Organizations that align product offerings with the nuanced requirements of discrete applications and that invest in lifecycle services will be better positioned to convert regulatory complexity into a competitive advantage. The interplay between tariff-driven sourcing adjustments, regional capability differences, and advances in encapsulation and delivery technologies creates both risks and pathways for differentiation.

Ultimately, success will favor entities that combine operational rigor, regulatory foresight, and a customer-centric approach to service delivery. By strengthening regional presence, diversifying sourcing strategies, and offering bundled technical and compliance solutions, stakeholders can enhance reliability and reduce the operational friction that often accompanies the handling and deployment of high-activity materials. The recommendations and insights presented here are intended to support informed decision-making and to guide strategic investments that prioritize safety, continuity, and long-term value creation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gamma Radioactive Sources Market, by Source Type

  • 8.1. Americium 241
  • 8.2. Cesium 137
  • 8.3. Cobalt 60
  • 8.4. Iridium 192

9. Gamma Radioactive Sources Market, by Product Form

  • 9.1. Sealed
  • 9.2. Unsealed

10. Gamma Radioactive Sources Market, by Activity Level

  • 10.1. High Activity
  • 10.2. Low Activity
  • 10.3. Medium Activity

11. Gamma Radioactive Sources Market, by Application

  • 11.1. Environmental Monitoring
  • 11.2. Food Irradiation
  • 11.3. Industrial Radiography
  • 11.4. Medical Radiotherapy
    • 11.4.1. Brachytherapy
      • 11.4.1.1. High Dose Rate
      • 11.4.1.2. Low Dose Rate
    • 11.4.2. External Beam Radiotherapy
  • 11.5. Oil And Gas
  • 11.6. Research And Development
  • 11.7. Sterilization

12. Gamma Radioactive Sources Market, by End User

  • 12.1. Food Processing Companies
  • 12.2. Hospitals
  • 12.3. Nuclear Power Plants
  • 12.4. Oil And Gas Companies
  • 12.5. Pharmaceuticals
  • 12.6. Research Institutions

13. Gamma Radioactive Sources Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Platforms

14. Gamma Radioactive Sources Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Gamma Radioactive Sources Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gamma Radioactive Sources Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Gamma Radioactive Sources Market

18. China Gamma Radioactive Sources Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Beijing Atom Hi-Tech Co., Ltd.
  • 19.6. Berthold Technologies GmbH & Co. KG
  • 19.7. Board of Radiation and Isotope Technology
  • 19.8. China Isotope & Radiation Corporation
  • 19.9. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 19.10. Institut national des radioelements SA
  • 19.11. International Isotopes Inc.
  • 19.12. Isotope Technologies Dresden GmbH
  • 19.13. NTP Radioisotopes SOC Ltd
  • 19.14. Nuclear Technology Products (Pty) Ltd
  • 19.15. Rosatom State Atomic Energy Corporation
  • 19.16. Sotera Health LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY AMERICIUM 241, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY AMERICIUM 241, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY AMERICIUM 241, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY CESIUM 137, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY CESIUM 137, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY CESIUM 137, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COBALT 60, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COBALT 60, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COBALT 60, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY IRIDIUM 192, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY IRIDIUM 192, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY IRIDIUM 192, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SEALED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SEALED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SEALED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY UNSEALED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY UNSEALED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY UNSEALED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH ACTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH ACTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH ACTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW ACTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW ACTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW ACTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDIUM ACTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDIUM ACTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDIUM ACTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY INDUSTRIAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY INDUSTRIAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY INDUSTRIAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD PROCESSING COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD PROCESSING COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY FOOD PROCESSING COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY NUCLEAR POWER PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY NUCLEAR POWER PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY NUCLEAR POWER PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY OIL AND GAS COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 183. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 210. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. G7 GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 219. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 223. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY ACTIVITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY MEDICAL RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA GAMMA RADIOACTIVE SOURCES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)